About Auroactive Pharma Private Limited
Data last updated:
Auroactive Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Aurobindo Pharma Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2020PTC138313. Its GSTIN is 37AATCA1565C1ZM (Andhra Pradesh).
The company has an authorised share capital of ₹250 Cr and a paid-up capital of ₹247 Cr. It is led by directors including Deepak Singh and Venkatanarayana Reddy Jayampu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.55 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹86.63 Cr (net margin -230.7%) and EBITDA of -₹47.93 Cr (EBITDA margin -127.6%).
The company has about 105 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aurobindo Pharma. As per MCA filings, the company has open charges of ₹425 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 1 deal on record (1 rights issue); the latest was in April 2021. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Almon Healthcare Private Limited with revenue of ₹38.26 Cr. The company has 6 MSME Form 1 returns on record between 2022 and 2024, listing 122 overdue payments to 33 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aurobindo.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Auroactive Pharma Private Limited
The main business activity of Auroactive Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Auroactive Pharma Private Limited FY 2025 filings available
Auroactive Pharma Private Limited reported revenue of ₹37.55 Cr (up 8244% YoY) for FY 2025.
Financial Statement Summary of Auroactive Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹47.93 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹86.63 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Auroactive Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -127.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -230.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Auroactive Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Auroactive Pharma Private Limited
Auroactive Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Almon Healthcare Private Limited | ₹38.26 Cr (FY 2025) | •••• | •••• | 58.0% | •••• | Ahmedabad, Gujarat, India |
| Vadivarhe Speciality Chemicals Limited Listed | ₹38.17 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Igatpuri, Maharashtra, India |
| Ad-Pharmachem Private Limited | ₹37.8 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Aurangabad, Maharashtra, India |
| Reliance Rasayan Private Limited | ₹37.71 Cr (FY 2025) | •••• | •••• | 509.0% | •••• | Ahmedabad, Gujarat, India |
| Ceyone Life Sciences Private Limited | ₹37.68 Cr (FY 2025) | •••• | •••• | 63.0% | •••• | Anakapalle, Andhra Pradesh, India |
| Auroactive Pharma Private Limited this company | ₹37.55 Cr (FY 2025) | •••• | •••• | 8244.0% | •••• | Hyderabad, Telangana, India |
| Shree Nath Life Sciences Private Limited | ₹37.39 Cr (FY 2025) | •••• | •••• | -28.0% | •••• | Delhi, India |
| Nira Life Sciences Private Limited | ₹37.1 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Rajkot, Gujarat, India |
| Nandesari Drugs and Pharmaceuticals Private Limited | ₹37.08 Cr (FY 2024) | •••• | •••• | 1417.0% | •••• | Delhi, India |
| Globela Industries Private Limited | ₹37.05 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Vagra, Gujarat, India |
| Chempro Pharma Private Limited | ₹37.02 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Auroactive Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Auroactive Pharma Private Limited
Auroactive Pharma Private Limited is audited by G P M & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G P M & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Auroactive Pharma Private Limited
Auroactive Pharma has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Singh | Director | 01 Feb 2023 | 3 Years 8 Months | Current |
| Venkatanarayana Reddy Jayampu | Director | 04 Nov 2024 | 1 Years 11 Months | Current |
| Thomas Koshy Vellutheril Also directs: Auropharm Overseas Limited, Auro Pharma Limited | Director | 19 May 2025 | 1 Years 4 Months | Current |
| Mylandlahalli Rammohan Ashwini Also directs: Apitoria Pharma Private Limited, Eugia Sez Private Limited, Apl Healthcare Limited and 3 more | Director | 16 May 2024 | 2 Years 4 Months | Current |
| Santhanam Subramanian Also directs: Engenra Biologics Private Limited, Avogent Lifesciences Private Limited, Tergene Biotech Limited and 5 more | Director | 01 Jul 2023 | 3 Years 3 Months | Current |
Ownership and Shareholding of Auroactive Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Auroactive Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Oct 2023 | State Bank of India | ₹425 Cr | Open |
Total charge records: 1 View all charges
Deals & Funding of Auroactive Pharma Private Limited
Auroactive Pharma Private Limited has 1 deal on record (1 rights issue); the latest was in April 2021.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2021 | Rights issue | ₹19 Cr | Investors: Aurobindo Pharma Ltd |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Auroactive Pharma Private Limited
Auroactive Pharma Private Limited has 1 court case on record: 1 filed by Auroactive Pharma. All case is pending. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Civil suit | Filed by the company against an individual | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Auroactive Pharma Private Limited
Auroactive Pharma Private Limited has 6 MSME Form 1 returns on record between 2022 and 2024, listing 122 overdue payments to 33 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 33)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Hussain Enterprise | •••• | •••• | •••• |
| Naga Pumps Private Limited | •••• | •••• | •••• |
| TFS Integrated Facility Management Services Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 6 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Auroactive Pharma Private Limited
Auroactive Pharma operates one associated brand: Aurobindo Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generic biocatalytic solutions are provided for pharmaceutical applications. | aurobindo.com |
Employees and EPFO Compliance at Auroactive Pharma Private Limited
Auroactive Pharma Private Limited has a workforce of 105 employees as of Apr 11, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Auroactive Pharma Private Limited
Auroactive Pharma Private Limited has 15 board changes on record since 2020: 10 appointments and 5 cessations. The latest: Thomas Koshy Vellutheril was appointed as Director on 19 May 2025.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Auroactive Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Auroactive Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Auroactive Pharma Private Limited
Auroactive Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AATCA1565C1ZM | Andhra Pradesh | Active | 01 Apr 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Auroactive Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Auroactive Pharma Private Limited
Auroactive Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 2020 (6+ years old) and is registered under CIN U24230TG2020PTC138313.
Auroactive Pharma reported revenue of ₹37.55 Cr for FY 2025 (up 8244% YoY).
Auroactive Pharma has 5 current directors:
- Deepak Singh - Director
- Venkatanarayana Reddy Jayampu - Director
- Thomas Koshy Vellutheril - Director
- Mylandlahalli Rammohan Ashwini - Director
- Santhanam Subramanian - Director
Auroactive Pharma reported a net loss of ₹86.63 Cr (net margin -230.7%) and EBITDA of -₹47.93 Cr (EBITDA margin -127.6%) for FY 2025, as per its filed financial statements.
The GSTIN of Auroactive Pharma is 37AATCA1565C1ZM, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Auroactive Pharma is U24230TG2020PTC138313. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Auroactive Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Auroactive Pharma was incorporated on 09 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Auroactive Pharma has 1 deal on record (1 rights issue); the latest was in April 2021.
The peers of Auroactive Pharma by revenue are Almon Healthcare Private Limited, Vadivarhe Speciality Chemicals Limited, Ad-Pharmachem Private Limited, Reliance Rasayan Private Limited, Ceyone Life Sciences Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Thomas Koshy Vellutheril was appointed as Director on 19 May 2025. Sivakumaran Meenakshisunderam ceased to be Director on 04 Nov 2024. Venkatanarayana Reddy Jayampu was appointed as Director on 04 Nov 2024. Auroactive Pharma has 15 board changes on record in total.
Auroactive Pharma has 6 MSME Form 1 returns on record between 2022 and 2024, listing 122 overdue payments to 33 micro and small suppliers. The latest return was filed on 01 May 2024.